Tran N. Chau

Tran N. Chau

Auto-generated profile, based on publicly available information

Tran N. Chau

Genetics, Bioinformatics, and Computational Biology, Virginia Tech, Blacksburg, VA 24060, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
TCTran N. Chau
Tran N. Chau
PTPrakash Raj Timilsena
Prakash Raj Timilsena
SBSai Pavan Bathala
Sai Pavan Bathala
SKSanchari Kundu
Sanchari Kundu
BBBastiaan Bargmann
Bastiaan Bargmann
SLsong li
song li
Single-cell RNA sequencing (scRNA-seq) is widely used in plant biology and is a powerful tool for studying cell identity and differentiation. However, the scarcity of known cell-type marker genes and the divergence of marker expression patterns limit the accuracy of cell-type identification and our capacity to investigate cell-type conservation in many species. To tackle this challenge, we devise a novel computational strategy called Orthologous Marker Gene Groups (OMGs), which can identify cell types in both model and non-model plant species and allows for rapid comparison of cell types across many published single-cell maps. Our method does not require cross-species data integration, while still accurately determining inter-species cellular similarities. We validate the method by analyzing published single-cell data from species with well-annotated single-cell maps, and we show our methods can capture majority of manually annotated cell types. The robustness of our method is further demonstrated by its ability to pertinently map cell clusters from 1 million cells, 268 cell clusters across 15 diverse plant species. We reveal 14 dominant groups with substantial conservation in shared cell-type markers across monocots and dicots. To facilitate the use of this method by the broad research community, we launch a user-friendly web-based tool called the OMG browser, which simplifies the process of cell-type identification in plant datasets for biologists.

22 January 2026 in Cancer Research
Verified
Journal Article
Open access
MBMathew Bloomfield
Mathew Bloomfield
SHSydney M. Huth
Sydney M. Huth
DMDaniella S. McCausland
Daniella S. McCausland
RSRon Saad
Ron Saad
NBNazia Bano
Nazia Bano
DCDaniela Cimini
Daniela Cimini
Whole genome doubling (WGD) is a frequent event in cancer evolution associated with chromosomal instability, metastasis, and poor prognosis. Whereas the genomic consequences of WGD are well documented, nongenetic alterations that accompany WGD, such as changes to cell and nuclear size, may also play an important role in tetraploid (4N) cancer cell physiology. In this study, we showed that cell and nuclear volume does not always scale with DNA content after WGD in cancer cells, resulting in 4N cells that differ in size. Small size was associated with enhanced cell fitness, mitotic fidelity, and tumorigenicity in 4N cancer cells and with poor patient survival in WGD-positive human cancers. Overall, these results suggest that cell and nuclear size may contribute to the tumorigenic potential of 4N cancer cells and could be an important prognostic marker in human tumors that undergo WGD. Significance: Cancer cell size varies after whole genome duplication, with smaller cells exhibiting high tumorigenicity and correlating with poor patient survival, demonstrating the clinical relevance and highlighting the biomarker potential of cell size.

30 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTran N. Chau
Tran N. Chau
KRKook Hui Ryu
Kook Hui Ryu
RARazan Alajoleen
Razan Alajoleen
BBBastiaan Bargmann
Bastiaan Bargmann
JSJohn Schiefelbein
John Schiefelbein
SLsong li
song li
Single-cell RNA sequencing (scRNA-seq) has become a powerful tool for uncovering transcriptomic heterogeneity and reconstructing gene regulatory networks in complex tissues. However, the sparsity, high noise levels, and dropout events inherent to scRNA-seq data pose challenges for accurate inference of gene-gene relationships. In this study scCoBench, we systematically benchmark correlation metrics, pseudo bulk analysis, and imputation methods using promoter-reporter and native gene pairs as internal controls to evaluate the performance of ten widely used gene-gene co-expression measurements. Interestingly, we found that commonly used data scaling and normalization approaches lead to lower correlation between promoter reporter and native gene pairs in most of the co-expression methods. Moreover, we assess the impact of five popular imputation techniques, including scImpute, SAVER, Autoencoder (AE), Variational Autoencoder (VAE), and Generative Adversarial Network (GAN) on recovering biologically relevant co-expression patterns. Our results demonstrate that imputation models not only markedly enhance correlation between each promoter-reporter and native gene pair but also increase the number of cells co-expressing both genes. Imputation also improved transcription factor target gene correlations and revealed stronger associations among genes within the same protein complex. This work highlights the utility of promoter-reporter systems for benchmarking computational methods and underscores the potential of deep learning-based imputation to improve the biologically relevant signals of scRNA-seq data.

17 June 2026
Verified
Other
Open access
MBMathew Bloomfield
Mathew Bloomfield
SHSydney M. Huth
Sydney M. Huth
DMDaniella S. McCausland
Daniella S. McCausland
RSRon Saad
Ron Saad
NBNazia Bano
Nazia Bano
DCDaniela Cimini
Daniela Cimini
Whole genome doubling (WGD) is a frequent event in cancer evolution associated with chromosomal instability, metastasis, and poor prognosis. Whereas the genomic consequences of WGD are well documented, nongenetic alterations that accompany WGD, such as changes to cell and nuclear size, may also play an important role in tetraploid (4N) cancer cell physiology. In this study, we showed that cell and nuclear volume does not always scale with DNA content after WGD in cancer cells, resulting in 4N cells that differ in size. Small size was associated with enhanced cell fitness, mitotic fidelity, and tumorigenicity in 4N cancer cells and with poor patient survival in WGD-positive human cancers. Overall, these results suggest that cell and nuclear size may contribute to the tumorigenic potential of 4N cancer cells and could be an important prognostic marker in human tumors that undergo WGD.Significance:Cancer cell size varies after whole genome duplication, with smaller cells exhibiting high tumorigenicity and correlating with poor patient survival, demonstrating the clinical relevance and highlighting the biomarker potential of cell size.

17 June 2026
Verified
Other
Open access
MBMathew Bloomfield
Mathew Bloomfield
SHSydney M. Huth
Sydney M. Huth
DMDaniella S. McCausland
Daniella S. McCausland
RSRon Saad
Ron Saad
NBNazia Bano
Nazia Bano
DCDaniela Cimini
Daniela Cimini
Tables reporting: transcriptional differences in large vs. small 4N cells; transcriptional differences in small vs. large 4N cells; transcriptional differences associated with nuclear size in WGD+ human tumors; and multivariate analysis of patient survival in small and large WGD+ cancers

17 June 2026
Verified
Other
Open access
MBMathew Bloomfield
Mathew Bloomfield
SHSydney M. Huth
Sydney M. Huth
DMDaniella S. McCausland
Daniella S. McCausland
RSRon Saad
Ron Saad
NBNazia Bano
Nazia Bano
DCDaniela Cimini
Daniela Cimini
MFISH data for whole chromosome gains or losses in DLD1 cells